Detection of ctDNA fractions with a single tumour-informed and tumour-agnostic profiling assay strongly predicts relapse in lung cancer By Ogkologos - October 27, 2026 3 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women... January 18, 2022 NHL Player Carey Price Surprises 11-Year-Old Boy Who Just Lost Mom... June 24, 2019 Large Study Confirms that HPV Vaccine Prevents Cervical Cancer October 14, 2020 US lung cancer data points to the power of cancer research August 18, 2020 Load more HOT NEWS Study Links Mental Health Treatment to Improved Cancer Survival Pan-FGFR Tyrosine Kinase Inhibitor Treatment Is Less Effective in Patients with... Plant-Based Diets and a New Treatment Combination for Prostate Cancer: Research... FDA Approves Imetelstat for Low- To Intermediate-1 Risk Myelodysplastic Syndromes with...
